Biotech | August 06, 2021
Mark W. Womack is the new CEO of Stelis Biopharma
He will be stationed at the company HQ in Bengaluru, India
He will be stationed at the company HQ in Bengaluru, India
CDSCO to fast-track trials and approval for COVID19 vaccine
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
Dr.Reddy's will receive U.S. $6 million upfront upon closing followed by U.S. $9 million one year from closing
The company has been consistently reducing debt
The data should be submitted by August 12th 2021
Deal for 100 million doses with additional 100 million through 2023
Innovative solutions and a deep understanding of the market makes this a unique combination
Subscribe To Our Newsletter & Stay Updated
